{
  "report_rows": [
    {
      "kpi": "FFO as Adjusted per share (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$0.43 vs. cons $0.395",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Senior Housing SS NOI Growth (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~+20-22% vs. cons +17.0%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Lab SS NOI Growth (Q2 2026)",
      "prediction": "IN-LINE",
      "answer": "pred ~-6 to -7% vs. cons -5.7%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FFO as Adjusted FY 2026 (FY)",
      "prediction": "BETTER",
      "answer": "guide ~$1.72-$1.76 mid vs. cons $1.570 (Adj) / $1.755 (Core)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Senior Housing SS NOI FY 2026 (FY)",
      "prediction": "BETTER",
      "answer": "guide ~+12-16% vs. cons +14.4%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Lab SS NOI FY 2026 (FY)",
      "prediction": "UNCHANGED",
      "answer": "guide -5% to -8% (tighten) vs. cons -4.9%",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": -2.3,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -4.0,
  "day5_path": "FADE",
  "day5_rationale": "FADE - beat-and-raise is mechanical (FY raise = Q2 beat flowing through), lab recovery remains a 2027 story, +11% pre-earnings run already priced in peer read-throughs and short covering",
  "day5_confidence": "MEDIUM"
}